Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib
Author(s): Afzal Sohaib Added: 1 year ago
ESC Congress 2022 — In this short and practice-focused review, Dr Afzal Sohaib,Electrophysiologist atBarts Health NHS Trust, shares his thoughts on the top 3 trials that will impact his practice. Trials covered in detail include: 00:18:eBRAVE-AF: eHealth-based Bavarian Alternative Detection of Atrial Fibrillation: A Randomized Controlled Trial 01:34:CAPLA: Catheter ablation for persistent… View more

Anticoagulation

Imaging & Diagnostics
Percutaneous Left Atrial Appendage Closure - Dr. Jacqueline Saw
Author(s): Jacqueline Saw Start date: May 07, 2015

Electrophysiology & Arrhythmia
View from the Thoraxcenter: What's Hot at ACC.24?
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 3 weeks ago
What’s hot at ACC.24?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24,… View more

Anticoagulation

Heart Failure
Vijay U Rao
Research Area(s) / Expertise:

Cardio-oncology

Heart Failure

Anticoagulation

Echocardiography & Ultrasound

 Job title: Director Heart Failure, Cardio-oncology and Co-Director Anticoagulation at Franciscan St Francis Health
Dr Vijay U Rao, MD is the Director of Heart Failure, Cardio-oncology, and Co-Director of Anticoagulation at Franciscan St Francis Health and Gorvernor of ACC Chapter of Indiana. Dr. Rao specializes in echocardiography, nuclear cardiology, heart failure and cardiovascular research. View more
Dual Antithrombotic Therapy With Dabigatran
Author(s): Christopher P Cannon Added: 6 years ago
This interview with Christopher P. Cannon from Brigham and Women's Hospital, Boston, US discusses Dual Antithrombotic Therapy with Dabigatran After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation (REDUAL-PCI). Filmed by Radcliffe Cardiology on-site at ESC 2017. View more

Anticoagulation
ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR
Author(s): Duk-Woo Park Added: 2 years ago
In this short interview, Dr Duk-Woo Park (Asan Medical Center, KR) discusses the findings from the ADAPT-TAVR Randomized Clinical Trial (NCT03284827). The trial investigated Edoxaban versus dual antiplatelet therapy for leaflet thrombosis and cerebral thromboembolism after TAVR. Presented first at ACC.22, ADAPT-TAVR shows that the overall incidence of leaflet thrombosis on CT scans was less… View more

Anticoagulation
View from the Thoraxcenter: ESC 22 Late-breaking Science Wrap-up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
What are the take-home messages from ESC 22 and what are the implications for practice? In this short wrap-up video of ESC 22, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) review the most impactful hot line and late-breaking trials of ESC Congress 2022. Trials covered in detail include: On clinical judgement after PCI 00:35:27:REVIVED-BCIS2: Study of… View more

Anticoagulation

Standards & Guidelines
Author(s): Oussama M Wazni , Allan L Klein Added: 3 years ago
Atrial fibrillation (AF) is the most commonly sustained arrhythmia with a prevalence of 0.4% in the general population1-4 affecting 2.3 million people in the US.5 The prevalence increases with age being <1% in persons younger than 60 years of age to >8% in those older than 80 years.1,5-8 The incidence ranges from 0.2% per year for men 30 to 39 years of age to 2.3% per year in men 80 to 89… View more

Imaging & Diagnostics
Author(s): Praveen Rao , Olusegun Olusesi , Mitchell Faddis Added: 3 years ago
It is presumed that the pathogenesis of stroke in atrial fibrillation (AF) patients is due to embolization of thrombus from the left atrium. Within the left atrium, the left atrial appendage is the predominant site of thrombus formation. In a study of 233 patients with new onset AF of greater than 48 hours in duration who were not anticoagulated, left atrial appendage thrombus was present in 15 %… View more

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
Robert F Storey
Job title: Professor and Honorary Consultant in Cardiology
Prof Robert Storey is Academic Director and an honorary Consultant Cardiologist for the Cardiology and Cardiothoracic Surgery Directorate, Sheffield Teaching Hospitals NHS Foundation Trust. He is Professor of Cardiology at the University of Sheffield, UK, where he has headed a platelet research group since 2002 within the Department of Cardiovascular Science. He has a special interest in the… View more